LAE119 has more efficient anti-proliferative effects on BRCA1/2-mutated breast, colon, and pancreatic cancer cell lines than does AZD5305 and exhibits substantial tumor inhibition with reduced toxicity in BRCA-mutated breast and pancreatic cancer CDX models [122]. Here, BRCA1 is linked to pancreatic neoplasm.